Virus News and Research

Latest Virus News and Research

Interim results of the effectiveness of 2022-2023 influenza vaccine from six studies conducted in Europe

Researchers provided interim results on 2022-2023 influenza vaccine effectiveness (VE) estimates.

30 May 2023

Cardiovascular disease is primed to kill more older adults, especially Blacks and Hispanics

Cardiovascular disease — the No. 1 cause of death among people 65 and older — is poised to become more prevalent in the years ahead, disproportionately affecting Black and Hispanic communities and exacting an enormous toll on the health and quality of life of older Americans.

30 May 2023

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

Novel EABR technology enhances potency and breadth of vaccine-induced responses through antigen presentation.

30 May 2023

Link confirmed: Infant RSV infections increase likelihood of childhood asthma

Research investigates the association between early-life respiratory syncytial virus (RSV) infection and the development of childhood asthma. It aims to assess the impact of RSV infection during infancy on the onset of wheezing illnesses and asthma in children.

30 May 2023

Study maps immune responses produced by COVID-19 vaccination in First Nations population

Published in Nature Immunology and Nature Briefing, the research is the first of its kind to decisively map immune responses produced by a COVID-19 vaccination in any First Nations populations.

29 May 2023

Novel treatment targets against natural killer/T-cell lymphoma identified

A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has discovered that a transcription factor, TOX2, was aberrantly increased in patients with Natural killer/T-cell lymphoma (NKTL).

29 May 2023

Virally mediated gene therapy could potentially treat genetic hearing loss

By 2050, one in 10 individuals are expected to live with some form of hearing loss. Of the hundreds of millions of cases of hearing loss affecting individuals worldwide, genetic hearing loss is often the most difficult to treat.

26 May 2023

MHRA authorizes new COVID-19 vaccine from SK Chemicals

SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

26 May 2023

Large study uncovers new details about long COVID

Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue and organ in the body.

26 May 2023

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to this year's recipient of the Pittsburgh Analytical Chemistry Award, Neil Kelleher, about his work in top-down proteinomics.

From Pittcon 26 May 2023

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2.

26 May 2023

How do the outcomes of viral coinfections vary across host species?

In a recent study published in the journal PLOS Pathogens, researchers investigated the outcomes of coinfections of two viruses — Drosophila C Virus (DCV) and Cricket Paralysis Virus (CrPV) in 25 inbred lines of Drosophila melanogaster and 47 other host species belonging to the Drosophilidae family.

26 May 2023

RECOVER study: An important step toward defining long COVID

A study led by the National Institutes of Health's RECOVER Initiative and supported by NYU Langone Health, home to the effort's Clinical Science Core (CSC), provides an expanded working definition of long COVID.

25 May 2023

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

New animal research is helping explain why at least five people have become HIV-free after receiving a stem cell transplant.

25 May 2023

Immune cells targeting core protein play an important role in early immune defense against COVID-19

LMU immunologists have studied the early immune response to acute SARS-CoV-2 infection and show how vaccines could be improved in future.

25 May 2023

The first thousand days of development

Study provides a bird's-eye view of the significant moments of the first thousand days of life.

25 May 2023

Exercise capacity found to be lower than expected among people with long COVID

While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.

25 May 2023

Unstable housing fuels risky behaviors among US high school students, CDC study warns

Youths experiencing unstable housing face elevated health risks, including poor physical and mental health outcomes. Disproportionate burden is observed among youths of color and sexual minority youths.

24 May 2023

Long-term exposure to air pollution associated with higher risk of developing severe COVID-19

A long history of exposure to air pollution is associated with a higher risk of developing severe disease, admission to hospital or an intensive care unit (ICU) and death by COVID‑19 according to a study led by the Barcelona Institute for Global Health (ISGlobal), a research centre supported by the "la Caixa" Foundation.

24 May 2023

SARS-CoV-2 infection linked to increased risk of type 1 diabetes in children

Different studies have documented an increased incidence of type 1 diabetes during the COVID-19 pandemic.

24 May 2023

Previous
1
...
92
93
94
95
96
97
98
...
1542
Next

Virus News and Research

Latest Virus News and Research

Interim results of the effectiveness of 2022-2023 influenza vaccine from six studies conducted in Europe

Cardiovascular disease is primed to kill more older adults, especially Blacks and Hispanics

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

Link confirmed: Infant RSV infections increase likelihood of childhood asthma

Study maps immune responses produced by COVID-19 vaccination in First Nations population

Novel treatment targets against natural killer/T-cell lymphoma identified

Virally mediated gene therapy could potentially treat genetic hearing loss

MHRA authorizes new COVID-19 vaccine from SK Chemicals

Large study uncovers new details about long COVID

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

How do the outcomes of viral coinfections vary across host species?

RECOVER study: An important step toward defining long COVID

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

Immune cells targeting core protein play an important role in early immune defense against COVID-19

The first thousand days of development

Exercise capacity found to be lower than expected among people with long COVID

Unstable housing fuels risky behaviors among US high school students, CDC study warns

Long-term exposure to air pollution associated with higher risk of developing severe COVID-19

SARS-CoV-2 infection linked to increased risk of type 1 diabetes in children

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in